Skip to content
Screener

Aehr Test Systems AEHR Financing Cash Flow

Financing Cash Flow at other companies

Teradyne, Inc. logo
Teradyne, Inc.TER
-$90.74M+33.7%
FormFactor logo
FormFactorFORM
-$1.2M+59.6%
Veeco Instruments logo
Veeco InstrumentsVECO
-$1.85M+60.8%
Benchmark Electronics logo
Benchmark ElectronicsBHE
-$30.25M+63.5%
Amkor Technology logo
Amkor TechnologyAMKR
$989.24M+182%
Amtech Systems logo
Amtech SystemsASYS
$57.17M

Other financials

Income statement

See full
Revenue$10.3M-43.7%
Gross profit$3.4M-53.1%
Operating income-$4.2M-278%
Net income-$3.2M-398%
EPS (diluted)-$0.10-400%

Balance sheet

See full
Cash & equivalents$116.4M+339%
Total debt$9.9M-8.8%
Total equity$219.5M+78.7%
Total assets$246.7M+66.1%

Cash flow

See full
Operating cash flow-$5.1M-0.9%
CapEx$1.9M-11.1%
Free cash flow-$7.1M+2.7%

Valuation

See full
Market cap$3.25B+498%
Enterprise value$3.15B+496%
P/S63.8×+55.8×

Profitability

See full
Gross margin39.5%-8.0pp
Operating margin14.3%+0.7pp
Net margin44.2%+27.4pp
FCF margin-27.1%

Returns & leverage

See full
Return on equity32.3%+20.3pp
Debt / equity0.0×
Current ratio10.3×+4.7×

Where this comes from

Reported directly by Aehr Test Systems in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The source filing: Aehr Test Systems’s 10-Q, filed April 8, 2026.

Filed
Apr 8, 2026, 4:05 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001654954-26-003348
(In thousands)Nine Months Ended / February 27, 2026Nine Months Ended / February 28, 2025
Proceeds from issuance of common stock from public offering, net of issuance costs19,595-
Proceeds from issuance of common stock under employee plans1,125894
Shares repurchased for tax withholdings on vesting of restricted stock units(1,273)(520)
Net cash provided by financing activities19,447374
Effect of exchange rate changes on cash, cash equivalents and restricted cash925
Net increase (decrease) in cash, cash equivalents and restricted cash10,581(17,948)
Cash, cash equivalents and restricted cash, beginning of period(1)26,48049,309
Cash, cash equivalents and restricted cash, end of period (1)$37,061$31,361

Item 1. Financial Statements (unaudited)

FAQ

What is Aehr Test Systems's financing cash flow?
Aehr Test Systems (AEHR) reported financing cash flow of $19.45M in Q1 2026.
How has Aehr Test Systems's financing cash flow changed year-over-year?
Aehr Test Systems's financing cash flow increased by 5099.7% year-over-year, from $374K to $19.45M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Ask your AI about Aehr Test Systems's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude